(Press-News.org) Researchers from the University of Basel have developed a virtual reality app for smartphones to reduce fear of heights. Now, they have conducted a clinical trial to study its efficacy. Trial participants who spent a total of four hours training with the app at home showed an improvement in their ability to handle real height situations.
Fear of heights is a widespread phenomenon. Approximately 5% of the general population experiences a debilitating level of discomfort in height situations. However, the people affected rarely take advantage of the available treatment options, such as exposure therapy, which involves putting the person in the anxiety-causing situation under the guidance of a professional. On the one hand, people are reluctant to confront their fear of heights. On the other hand, it can be difficult to reproduce the right kinds of height situations in a therapy setting.
This motivated the interdisciplinary research team led by Professor Dominique de Quervain to develop a smartphone-based virtual reality exposure therapy app called Easyheights. The app uses 360° images of real locations, which the researchers captured using a drone. People can use the app on their own smartphones together with a special virtual reality headset.
Gradually increasing the height
During the virtual experience, the user stands on a platform that is initially one meter above the ground. After allowing acclimatization to the situation for a certain interval, the platform automatically rises. In this way, the perceived distance above the ground increases slowly but steadily without an increase in the person's level of fear.
The research team studied the efficacy of this approach in a randomized, controlled trial and published the results in the journal NPJ Digital Medicine. Fifty trial participants with a fear of heights either completed a four-hour height training program (one 60-minute session and six 30-minute sessions over the course of two weeks) using virtual reality, or were assigned to the control group, which did not complete these training sessions.
Before and after the training phase - or the same period of time without training - the trial participants ascended the Uetliberg lookout tower near Zurich as far as their fear of heights allowed them. The researchers recorded the height level reached by the participants along with their subjective fear level at each level of the tower. At the end of the trial, the researchers evaluated the results from 22 subjects who completed the Easyheights training and 25 from the control group.
The group that completed the training with the app exhibited less fear on the tower and was able to ascend further towards the top than they could before completing the training. The control group exhibited no positive changes. The efficacy of the Easyheights training proved comparable to that of conventional exposure therapy.
Therapy in your own living room
Researchers have already been studying the use of virtual reality for treating fear of heights for more than two decades. "What is new, however, is that smartphones can be used to produce the virtual scenarios that previously required a technically complicated type of treatment, and this makes it much more accessible," explains Dr. Dorothée Bentz, lead author of the study.
The results from the study suggest that the repeated use of a smartphone-based virtual reality exposure therapy can greatly improve the behavior and subjective state of well-being in height situations. People who suffer from a mild fear of heights will soon be able to download the free app from major app stores and complete training sessions on their own. However, the researchers recommend that people who suffer from a serious fear of heights only use the app with the supervision of a professional.
The current study is one of several projects in progress at the Transfaculty Research Platform for Molecular and Cognitive Neurosciences, led by Professor Andreas Papassotiropoulos and Professor Dominique de Quervain. Their goal is to improve the treatment of mental disorders through the use of new technologies and to make these treatments widely available.
INFORMATION:
Rituximab, an anti-cancer drug targeting the membrane protein CD20, was the first approved therapeutic antibody against B tumor cells. Immunologists at the University of Freiburg have now solved a mystery about how it works. A team headed by Professor Dr. Michael Reth used cell cultures, healthy cells, and cells from cancer patients to investigate how CD20 organizes the nanostructures on the B cell membrane. If the protein is missing or Rituximab binds to it, the organization of the B cell surface changes. The resting B cell is activated in the process. The team has published the research in the journal PNAS as part of contributions by new members of the National Academy of Science.
B cells are white blood cells and part of the immune system. When they recognize ...
Oncotarget recently published "Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment" which reported that a retrospective study included 955 patients of various stages of prostate cancer who received combined hormone radiation treatment from 2000 to 2019. Comprehensive statistical methods were used to analyze the overall survival rate of PCa patients treated with melatonin in various prognosis groups.
The overall survival rate of PCa patients with favorable and intermediate prognoses treated or not treated ...
JACKSONVILLE, Fla. (February 10, 2021) - Brain volume, verbal IQ, and overall IQ are lower in children with Type 1 diabetes (T1D) than in children without diabetes, according to a new longitudinal study published in Diabetes Care, a journal of the American Diabetes Association. The nearly eight-year study, led by Nelly Mauras, MD, a clinical research scientist at Nemours Children's Health System in Jacksonville, Florida, and Allan Reiss MD, a Professor at the Stanford University School of Medicine in California, compared brain scans of young children who have T1D with those of non-diabetic children to assess the extent to which glycemic exposure may adversely affect the ...
It was reported that volume of the brain areas such as superior temporal gyrus and anterior cingulate cortex reduces in schizophrenia but precise change of three-dimensional structure of neuron has remains unclear.
Dr. Itokawa and colleague performed Nanotomography experiments using Fresnel zone plate optics at the BL37XU beamline of the SPring-8 synchrotron radiation facility and at the 32-ID beamline of the Advanced Photon Source (APS) of Argonne National Laboratory.
A total of 34 three-dimensional image datasets of layer V of the BA22 cortex were blinded ...
The recent review, published in Environment International and led by the University of Tartu, summarises the effect of aquatic pollution on cancer prevalence in wild animals with the help of more than 300 reviewed studies. Authors shed light on understudied yet important fields in cancer research in wild animals - summarising the key effects and pointing to future research avenues to crack the puzzle of why cancer develops in polluted environments.
„What was immediately evident was the bias towards fish in current research into aquatic wildlife cancer. However, given this bias it is especially interesting ...
Sophia Antipolis, 10 February 2021: A nationwide US study has found increasing death rates from heart disease in women under 65. The research is published in European Heart Journal - Quality of Care and Clinical Outcomes, a journal of the European Society of Cardiology (ESC).1 The study found that while death rates from cancer declined every year between 1999 and 2018, after an initial drop, heart disease death rates have been rising since 2010.
"Young women in the US are becoming less healthy, which is now reversing prior improvements in heart disease deaths," said senior author Dr. Erin Michos of Johns Hopkins University School of Medicine, Baltimore, US. "With ...
Satellite images reveal that the timing of algal blooms in the Red Sea may affect the next haul of sardines and squid by commercial fisheries.
Rising temperatures in the Red Sea have changed the timing of phytoplankton blooms. These microscopic algae form the base of many marine food webs and so are critical to ocean biodiversity and the industries that they support on land, such as fisheries and tourism.
A team led by KAUST climate modeler Ibrahim Hoteit has used satellite images to study the phenology of algal blooms in the northern Red Sea and ...
A new method has enabled the natural structure of particularly large and complex enzymes to be revealed. Scientists at Martin Luther University Halle-Wittenberg (MLU) and TU Berlin have published their findings in the journal Cell Reports. They investigated a multi-enzyme complex that plays an essential role in metabolism and have discovered that it functions differently than previously thought. This will help scientists better understand certain diseases.
Enzymes are a cell's biocatalysts. They accelerate chemical reactions in the body or ensure that these reactions even take place at all. As a result, they play an extremely important role in metabolism. Individual enzymes frequently form a complex with many subunits, as in the case of the ...
In a study conducted at the University of Helsinki, Finland, 136 adults adhered to one of three study diets for 12 weeks. One of them corresponded to the average Finnish diet, containing roughly 70% animal-derived protein of total protein, while most of the plant-based protein originated from cereal products. In the second study diet, half of the protein was derived from plant products and the other half from animal products, while the third one contained 30% animal protein and 70% plant-based protein of total protein.
Sources of animal protein, both red and white meat as well as dairy products, were partially replaced with plant-based proteins by adding a diverse range of legumes, nuts, ...
Your breath holds the key to monitoring fat burning, and now a research group from Tohoku University has created a compact and low-cost device that can measure how our body metabolizes fat.
The device uses an ultraviolet lamp to gauge exhaled acetone gas, which is produced in the blood through the metabolic reaction of fat.
"Precise measurements of acetone gas concentration allows us to determine the body's ability to metabolize fat and develop exercise methods for efficient fat burning," says Professor Yuji Matsuura from Tohoku University's Graduate School of Biomedical ...
